Connor, Clark & Lunn Investment Management Ltd.

Position in RYTM — Rhythm Pharmaceuticals, Inc.

CIK 1596800 VANCOUVER, A1

Position in RYTM

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$13,205,698

-$2,783,187 QoQ

Shares Held

151,842

+1.7% QoQ

Ownership

0.222%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2022

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $706,217,774 across 100 Biotechnology names. RYTM ranks #12 (1.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	251,711	$112,399,029
2	IONS	Ionis Pharmaceuticals Inc	874,089	$65,635,343
3	ARWR	Arrowhead Pharmaceuticals, Inc.	836,981	$52,478,708
4	MIRM	Mirum Pharmaceuticals, Inc.	479,476	$44,293,992
5	REGN	Regeneron Pharmaceuticals, Inc.	32,164	$24,851,192
6	AXSM	Axsome Therapeutics, Inc.	134,792	$22,782,543
7	SRPT	Sarepta Therapeutics, Inc.	1,019,951	$22,194,133
8	TERN	Terns Pharmaceuticals, Inc.	384,681	$20,280,382

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$13,205,698	151,842	+1.7%	Shares	Sole	2026-05-11
2025-12-31	$15,988,885	149,373	+23.2%	Shares	Sole	2026-02-10
2025-09-30	$12,246,047	121,260	+5.3%	Shares	Sole	2025-11-13
2025-06-30	$7,274,306	115,118	+127.7%	Shares	Sole	2025-08-07
2025-03-31	$2,678,004	50,557	+730.3%	Shares	Sole	2025-05-12
2024-12-31	$340,862	6,089	-34.8%	Shares	Sole	2025-02-10
2024-06-30	$383,500	9,340	-3.5%	Shares	Sole	2024-08-09
2024-03-31	$419,217	9,675	-85.2%	Shares	Sole	2024-05-09
2023-12-31	$3,013,057	65,544	-50.2%	Shares	Sole	2024-02-09
2023-09-30	$3,018,351	131,662	+126.5%	Shares	Sole	2023-11-13
2023-06-30	$958,382	58,119	+417.8%	Shares	Sole	2023-08-10
2022-06-30	$46,583	11,225	—	Shares	Sole	2022-08-05
No filing history on record for this holder in this stock.